Farchoukh et al. (38) also found that although the presence of the BRAF mutation is indicative of a sporadic cancer, up to 30–50% of colorectal carcinomas with MLH1 promoter hypermethylation will lack a BRAF mutation. The gene discussed is MLH1; the disease is cancer.